Crohn-betegség: vizsgálatok itt: Guatemala

1 trial · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  Where

  Guatemala City

  Életkor

  16 év to 80 év

  People

  600 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT06819878 · EU 2024-513053-69-00